Annual Financials for Laboratory Corp. of America Holdings
Fiscal year is January-December. All values USD millions. |
2016 | 2017 | 2018 | 2019 | 2020 |
5-year trend |
Sales/Revenue
|
9.64B | 10.31B | 11.33B | 11.55B | 13.98B | |
Sales Growth |
- | 6.91% | 9.95% | 1.95% | 20.98% | |
Cost of Goods Sold (COGS) incl. D&A |
6.64B | - | 8.39B | 8.55B | 9.3B | |
COGS excluding D&A |
6.15B | 6.9B | 7.84B | 7.77B | 8.48B | |
Depreciation & Amortization Expense |
490.6M | 533.2M | 552.1M | 771.3M | 825M | |
Depreciation |
311.1M | 316.7M | 320.4M | 515.6M | 549.6M | |
Amortization of Intangibles |
179.5M | 216.5M | 231.7M | 243.2M | 275.4M | |
COGS Growth |
- | - | - | 1.87% | 8.84% | |
Gross Income |
3B | 2.88B | 2.94B | 3.01B | 4.68B | |
Gross Income Growth |
- | -4.19% | 2.41% | 2.19% | 55.43% | |
Gross Profit Margin |
- | - | - | - | 33.46% | NA |
|
2016 | 2017 | 2018 | 2019 | 2020 |
5-year trend |
SG&A Expense |
1.6B | - | 1.57B | 1.57B | 1.71B | |
Research & Development |
- | - | - | - | - | |
Other SG&A |
1.6B | 1.5B | 1.57B | 1.57B | 1.71B | |
SGA Growth |
- | - | - | -0.10% | 8.82% | |
Other Operating Expense |
- | - | - | - | - | |
Unusual Expense |
94.9M | - | 48.1M | 114.9M | 524.2M | |
EBIT after Unusual Expense |
1.31B | - | (48.1M) | 1.33B | 2.45B | |
Non Operating Income/Expense |
2.6M | (6M) | 167.7M | 2M | (32.1M) | |
Non-Operating Interest Income |
1.7M | 2.1M | 7.5M | 8.8M | 10.3M | |
Equity in Affiliates (Pretax) |
7.9M | 11.3M | 11.6M | 9.8M | 2.9M | |
Interest Expense |
213.5M | - | 244.2M | 240.7M | 207.4M | |
Interest Expense Growth |
- | - | - | -1.43% | -13.83% | |
Gross Interest Expense |
213.5M | 235.1M | 244.2M | 240.7M | 207.4M | |
Interest Capitalized |
- | - | - | - | - | |
Pretax Income |
1.11B | 1.08B | 1.27B | 1.1B | 2.22B | |
Pretax Income Growth |
- | -2.53% | 17.71% | -12.88% | 100.84% | |
Pretax Margin |
- | - | - | - | 15.88% | NA |
Income Tax |
372.3M | (155.4M) | 384.4M | 280M | 662.1M | |
Income Tax - Current Domestic |
273.7M | 333.7M | 287M | 166.9M | 628.1M | |
Income Tax - Current Foreign |
43.9M | 53M | 64.3M | 83.9M | 81M | |
Income Tax - Deferred Domestic |
70.4M | (536.4M) | 27.5M | 40.7M | (34.8M) | |
Income Tax - Deferred Foreign |
(15.7M) | (5.7M) | 5.6M | (11.5M) | (12.2M) | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | - | - | - | - | |
Consolidated Net Income |
733.2M | 1.23B | 883.9M | 824.9M | 1.56B | |
Minority Interest Expense |
1.1M | 5.8M | 200,000 | 1.1M | 900,000 | |
Net Income |
732.1M | - | 883.7M | 823.8M | 1.56B | |
Net Income Growth |
- | - | - | -6.78% | 88.89% | |
Net Margin Growth |
- | - | - | - | 11.13% | NA |
Extraordinaries & Discontinued Operations |
- | - | - | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
- | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
- | - | - | - | - | |
Net Income After Extraordinaries |
732.1M | - | 883.7M | 823.8M | 1.56B | |
Preferred Dividends |
- | - | - | - | - | |
Net Income Available to Common |
732.1M | - | 883.7M | 823.8M | 1.56B | |
EPS (Basic) |
7.14 | 11.98 | 8.72 | 8.41 | 15.99 | |
EPS (Basic) Growth |
- | 67.83% | -27.27% | -3.45% | 90.06% | |
Basic Shares Outstanding |
102.5M | 102.4M | 101.4M | 97.9M | 97.3M | |
EPS (Diluted) |
7.02 | - | 8.61 | 8.36 | 15.88 | |
EPS (Diluted) Growth |
- | - | - | -3.00% | 90.05% | |
Diluted Shares Outstanding |
104.3M | 103.9M | 102.6M | 98.6M | 98M | |
EBITDA |
1.89B | - | 1.93B | 2.21B | 3.79B | |
EBITDA Growth |
- | - | - | 14.81% | 71.61% | |
EBITDA Margin |
- | - | - | - | 27.15% | NA |